Copyright
©The Author(s) 2015.
World J Hepatol. Nov 18, 2015; 7(26): 2664-2675
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2664
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2664
Name | Constituents | Accuracy (%) | |||
Se | Sp | PPV | NPV | ||
Indirect markers | |||||
APRI | AST, platelets | 41 | 95 | 88 | 64 |
FibroTest | α2 macroglobulin, α2 and γ globulin, total bilirubin, apolipoprotein A1, γGT | 87 | 59 | 63 | 85 |
Direct markers | |||||
ELF | PIIINP, HA, TIMP-1, (age) | 90.5 | 41 | 99 | 92 |
FibroSpect | HA, TIMP-1, γ2 macroglobulin | 77 | 73 | 74 | 76 |
- Citation: Trovato FM, Tognarelli JM, Crossey MM, Catalano D, Taylor-Robinson SD, Trovato GM. Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World J Hepatol 2015; 7(26): 2664-2675
- URL: https://www.wjgnet.com/1948-5182/full/v7/i26/2664.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i26.2664